IDERA PHARMACEUTICALS INC - COM NEW (IDRA)

CUSIP: 45168K306

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM NEW
Total 13F shares
92,318,683
Share change
+20,813,117
Total reported value
$169,812,917
Put/Call ratio
12%
Price per share
$1.84
Number of holders
105
Value change
+$36,240,312
Number of buys
56
Number of sells
43

Quarterly Holders Quick Answers

What is CUSIP 45168K306?
CUSIP 45168K306 identifies IDRA - IDERA PHARMACEUTICALS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q1 2018

As of 31 Mar 2018, IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by 105 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 92,318,683 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, FMR LLC, NATIXIS, Artal Group S.A., JPMORGAN CHASE & CO, STATE STREET CORP, and GMT CAPITAL CORP. This page lists 105 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.